The Nasdaq 100 has fallen about 6.5% from its October 6 record high amid ongoing geopolitical tensions and steady macroeconomic conditions. Despite this, the broader market shows signs of a stealth bear market, with around 55% of S&P 500 stocks trading below their 50-day averages and the Russell 2000 in correction territory. The S&P 500 trades at a forward P/E of 18.8, below its 5- and 10-year averages, while Q3 earnings growth is tracking around 29%, expected to exceed 35%. Growth is expanding beyond the top tech stocks, and midterm election seasonality suggests Q4 lows likely occurred in October. The analyst sees about 7% downside risk in a severe scenario but much greater upside potential, leading to an upgrade of the S&P 500 to a strong buy based on current sentiment and fundamentals.
The Nasdaq 100's recent 6.5% decline sets the backdrop for this story on U.S. stocks as a generational buy. For readers following U.S. equities, here is Pluang's market snapshot as of Oct 19, 2026 19:41 WIB: out of 150 priced US stocks tradable on Pluang, 77 rose and 70 fell today. Notable gainers include ASX (ASE Technology Holding Co Ltd) at USD 41.49 with a 4.96% increase, MRVL (Marvell Technology Inc) at USD 238.15 up 4.53%, and FCEL (FuelCell Energy Inc) at USD 13.55 rising 4.23%.
Disc Medicine's stock surged 38% following positive Phase 3 trial results for its drug bitopertin, which showed efficacy and safety in treating erythropoietic protoporphyria. BMO Capital raised its price target from $100 to $120 and maintained an Out...
Qualcomm executive Ann C. Chaplin sold 1,827 shares of the company's stock for $319,268.25 under a Rule 10b5-1 trading plan, reducing her holdings by 6.62%. Qualcomm's stock price recently traded below its 50-day and 200-day moving averages, signalin...
BOK Financial is set to announce its Q3 2026 earnings after market close on October 19, with analysts forecasting earnings per share between $2.52 and $2.54 and revenue near $571 million. The company has a strong history of surpassing earnings estima...
AIBotics has completed the acquisition of NovaCore Labs' assets from PlayJamaica Limited, gaining technology, software, drones, mapping equipment, and customer contracts. This move expands AIBotics' platform in Jamaica and the Caribbean, enhancing AI...
EyePoint's stock dropped sharply after its DURAVYU treatment did not meet the primary endpoint in a Phase 3 trial for wet age-related macular degeneration (wet AMD). Although DURAVYU showed some vision improvement and reduced the need for additional ...
